Article Text

Download PDFPDF
Primary nasopharyngeal tuberculosis
  1. Rasads Misirovs1,2,
  2. Lisa Johnston3 and
  3. Richard Green4
  1. 1Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK
  2. 2Doctoral studies, Riga Stradins University, Riga, Latvia
  3. 3Department of Histopathology, Ninewells Hospital and Medical School, Dundee, UK
  4. 4Department of Otorhinolaryngology, Ninewells Hospital and Medical School, Dundee, UK
  1. Correspondence to Mr Rasads Misirovs; rasads.misirovs{at}


No part of the human body is immune to tuberculosis, the most common site being the lungs. We report a rare case of primary nasopharyngeal tuberculosis without cervical lymphadenopathy nor pulmonary involvement. The only presenting symptom was an intermittent discomfort in the neck and throat. Several biopsies were performed to exclude nasopharyngeal carcinoma and to reach the final diagnosis of tuberculosis. The patient made full recovery following 6 months of treatment with antibiotics. A multidisciplinary approach by ear, nose and throat, radiology, pathology, and infectious disease colleagues was crucial in reaching the diagnosis and managing the patient.

  • Ear, nose and throat/otolaryngology
  • TB and other respiratory infections
  • Pathology
  • Radiology
  • Tuberculosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors RM wrote the draft, created figures 2 and 3, and revised the manuscript. LJ checked the draft, created figure 1 and revised the manuscript. RG participated in checking and amending the draft, and revised the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.